Overview

A Study of IBI351 in Healthy Subjects

Status:
Not yet recruiting

Trial end date:
2023-05-29

Target enrollment:

Participant gender:

Summary

This is an open-label, two-cycle clinical study to evaluate the drug interaction between itraconazole or dextromethorphan and IBI351 in healthy subjects. A total of two cohorts of 12 healthy male subjects were planned to be enrolled in each cohort.

Phase:

Phase 1

Details

Lead Sponsor:

Innovent Biologics (Suzhou) Co. Ltd.

Treatments:

Dextromethorphan
Itraconazole